Medical Financial Statements From 2010 to 2025

MSIU Stock  USD 0.0004  0.00  0.00%   
Analyzing historical trends in various income statement and balance sheet accounts from Medical Supply's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Medical Supply's valuation are summarized below:
Medical Supply International does not presently have any fundamental ratios for analysis.
Check Medical Supply financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medical Supply's main balance sheet or income statement drivers, such as , as well as many indicators such as . Medical financial statements analysis is a perfect complement when working with Medical Supply Valuation or Volatility modules.
  
This module can also supplement various Medical Supply Technical models . Check out the analysis of Medical Supply Correlation against competitors.

Medical Supply International Company Profit Margin Analysis

Medical Supply's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Medical Supply Profit Margin

    
  (1.73) %  
Most of Medical Supply's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medical Supply International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Medical Supply International has a Profit Margin of -1.7326%. This is 84.54% lower than that of the Healthcare sector and 68.27% lower than that of the Medical Devices industry. The profit margin for all United States stocks is 36.43% higher than that of the company.

Medical Supply Inter Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Medical Supply's current stock value. Our valuation model uses many indicators to compare Medical Supply value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medical Supply competition to find correlations between indicators driving Medical Supply's intrinsic value. More Info.
Medical Supply International is considered to be number one stock in return on asset category among its peers. It is regarded fifth in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medical Supply's earnings, one of the primary drivers of an investment's value.

About Medical Supply Financial Statements

Medical Supply shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Medical Supply investors may analyze each financial statement separately, they are all interrelated. The changes in Medical Supply's assets and liabilities, for example, are also reflected in the revenues and expenses on on Medical Supply's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Medical Supply International USA, Inc., together with its subsidiaries, provides rehabilitation services and specialized hospital services in the healthcare industry in the Peoples Republic of China. Medical Supply International USA, Inc. was founded in 2001 and is headquartered in Wan Chai, Hong Kong. Medical Supply is traded on OTC Exchange in the United States.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Medical Pink Sheet Analysis

When running Medical Supply's price analysis, check to measure Medical Supply's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Supply is operating at the current time. Most of Medical Supply's value examination focuses on studying past and present price action to predict the probability of Medical Supply's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Supply's price. Additionally, you may evaluate how the addition of Medical Supply to your portfolios can decrease your overall portfolio volatility.